Posted in Marketing.
rev="post-1306" 3 comments
Once I wrote about personal branding and my early internet and microcomputer experiences.
Now I have a new reason to write: I’m fighting the biggest battle of my life. I’ve been diagnosed with ATTRwt – transthyretin amyloidosis, wild type – a previously untreatable rare disease that affects primarily my heart.
Now, that Vyndaquel (Tafamidis) has received FDA approval, I’m hoping to share my experience and knowledge. Early diagnosis is the key!
……………………………………………..
(c) 2019 Walter Feigenson
……………………………………………..
Proudly powered by WordPress and Carrington.
Recent Comments